Yun Feng Li

Yun Feng Li

Director of Finance/CFO at MABPHARM LIMITED

Net worth: - $ as of 2024-04-29

47 year
Commercial Services
Consumer Services
Health Technology

Yun Feng Li active positions

CompaniesPositionStartEnd
MABPHARM LIMITED Director/Board Member 2018-07-19 -
Director of Finance/CFO 2018-07-19 -
Corporate Secretary 2018-07-19 -
Taizhou Mabtech Biotechnology Ltd. Corporate Officer/Principal 2016-02-29 -
Taizhou Mabtech Pharmaceutical Co. Ltd. Corporate Officer/Principal 2016-02-29 -

Career history of Yun Feng Li

Former positions of Yun Feng Li

CompaniesPositionStartEnd
Shanghai Sinomab Biotechnology Co. Ltd. Corporate Officer/Principal 2016-02-29 2018-07-31
Shanghai Biomabs Pharmaceuticals Co., Ltd. Corporate Officer/Principal 2016-02-29 2018-07-31
Shanghai Zhangjiang Biotechnology Co. Ltd. Corporate Officer/Principal 2016-02-29 2017-06-30
Corporate Officer/Principal 2012-11-30 2016-02-29
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD Corporate Officer/Principal 2010-06-30 2012-10-31
Shanghai National Engineering Research Center of Antibody Medi Corporate Officer/Principal 2009-06-30 2010-05-31
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Training of Yun Feng Li

Nanjing Normal University Undergraduate Degree

Statistics

International

China 10
Hong Kong 2

Operational

Corporate Officer/Principal 9
Director/Board Member 1
Director of Finance/CFO 1

Sectoral

Commercial Services 2
Consumer Services 2
Health Technology 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
MABPHARM LIMITED

Commercial Services

SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD

Health Technology

Private companies7
Taizhou Mabtech Biotechnology Ltd.

Taizhou Mabtech Pharmaceutical Co. Ltd.

Shanghai National Engineering Research Center of Antibody Medi

Finance

Shanghai Zhangjiang Biotechnology Co. Ltd.

Shanghai Biomabs Pharmaceuticals Co., Ltd.

Shanghai Sinomab Biotechnology Co. Ltd.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW